Sodium ferric gluconate complex
(PKNUOQOQWGOWBO-ZBHRUSISSA-M)
Structure
- SMILES
- OC[C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O.[Na+].[Fe+3]
- Molecular Formula:
- C6H11FeNaO7+++
- Molecular Weight:
- 273.982
- Log P:
- -4.8303
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 5
- TPSA:
- 141.28
- CAS Number(s):
- 34089-81-1
Synonym(s)
1.
Sodium ferric gluconate complex
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hypotension | FAERS: 4 Canada Vigilance: 14 | Canada Vigilance US FAERS | |
| 2 | Urticaria | FAERS: 3 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 3 | Abdominal Pain | FAERS: 2 Canada Vigilance: 17 | Canada Vigilance OFFSIDES US FAERS | |
| 4 | Angioedema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 5 | Arthralgia | FAERS: 1 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 6 | Arthritis | FAERS: 1 | US FAERS | |
| 7 | Burning sensation | FAERS: 1 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 8 | Chest discomfort | FAERS: 1 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 9 | Dizziness | FAERS: 1 Canada Vigilance: 13 | Canada Vigilance OFFSIDES US FAERS | |
| 10 | Fatigue | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 11 | Flushing | FAERS: 1 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 12 | Hypersensitivity | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 13 | Joint swelling | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Medication Error | FAERS: 1 | US FAERS | |
| 15 | Muscle tightness | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance OFFSIDES US FAERS | |
| 16 | Musculoskeletal stiffness | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 17 | Nausea | FAERS: 1 Canada Vigilance: 23 | Canada Vigilance OFFSIDES US FAERS | |
| 18 | Proctitis | FAERS: 1 | US FAERS | |
| 19 | Product label issue | FAERS: 1 | US FAERS | |
| 20 | Product substitution issue | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 21 | Product use issue | FAERS: 1 | US FAERS | |
| 22 | Pruritus | FAERS: 1 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 23 | Serum Sickness | FAERS: 1 | US FAERS | |
| 24 | Tongue discomfort | FAERS: 1 | US FAERS | |
| 25 | Tremor | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 26 | Unresponsive to stimuli | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance OFFSIDES US FAERS | |
| 27 | Vomiting | FAERS: 1 Canada Vigilance: 16 | Canada Vigilance US FAERS | |
| 28 | Abasia | OFFSIDES | ||
| 29 | Abdominal discomfort | Canada Vigilance: 2 | Canada Vigilance OFFSIDES | |
| 30 | Acidosis | OFFSIDES | ||
| 31 | Acute Coronary Syndrome | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Adenocarcinoma | OFFSIDES | ||
| 33 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Alopecia | OFFSIDES | ||
| 35 | Altered state of consciousness | Canada Vigilance: 2 | Canada Vigilance | |
| 36 | Amphetamines | OFFSIDES | ||
| 37 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 38 | Angina Pectoris | Canada Vigilance: 1 | Canada Vigilance | |
| 39 | Angiodysplasia | OFFSIDES | ||
| 40 | Anhedonia | OFFSIDES | ||
| 41 | Anorexia | OFFSIDES | ||
| 42 | Anxiety | Canada Vigilance: 3 | Canada Vigilance OFFSIDES | |
| 43 | Arteriosclerosis Obliterans | OFFSIDES | ||
| 44 | Arteriovenous fistula aneurysm | OFFSIDES | ||
| 45 | Arteriovenous fistula site complication | OFFSIDES | ||
| 46 | Asthenia | Canada Vigilance: 4 | Canada Vigilance OFFSIDES | |
| 47 | Ataxia | OFFSIDES | ||
| 48 | Atopy | OFFSIDES | ||
| 49 | Atrial tachycardia | OFFSIDES | ||
| 50 | Back Pain | Canada Vigilance: 26 | Canada Vigilance | |
| 51 | Band neutrophil percentage increased | OFFSIDES | ||
| 52 | Blindness | Canada Vigilance: 1 | Canada Vigilance | |
| 53 | Blood iron decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | Blood iron increased | OFFSIDES | ||
| 55 | Blurred vision | OFFSIDES | ||
| 56 | Bone pain | OFFSIDES | ||
| 57 | Bradycardia | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 58 | Bulbar palsy | OFFSIDES | ||
| 59 | Cardiac Death | OFFSIDES | ||
| 60 | Cerebral hypoperfusion | OFFSIDES | ||
| 61 | Chest Pain | Canada Vigilance: 11 | Canada Vigilance OFFSIDES | |
| 62 | Chills | Canada Vigilance: 2 | Canada Vigilance | |
| 63 | Choking sensation | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 64 | Circumstance or information capable of leading to medication error | OFFSIDES | ||
| 65 | Clostridium difficile colitis | OFFSIDES | ||
| 66 | Cold sweat | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 67 | Congenital cystic kidney disease | OFFSIDES | ||
| 68 | Crying | Canada Vigilance: 2 | Canada Vigilance | |
| 69 | Cyanosis | OFFSIDES | ||
| 70 | Dehydration | OFFSIDES | ||
| 71 | Demyelination | OFFSIDES | ||
| 72 | Depressed Level of Consciousness | Canada Vigilance: 3 | Canada Vigilance OFFSIDES | |
| 73 | Diabetes mellitus inadequate control | OFFSIDES | ||
| 74 | Diarrhea | OFFSIDES | ||
| 75 | Discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | Drug exposure during pregnancy | OFFSIDES | ||
| 77 | Drug ineffective | Canada Vigilance: 1 | Canada Vigilance | |
| 78 | Dry skin | OFFSIDES | ||
| 79 | Dysgeusia | Canada Vigilance: 1 | Canada Vigilance | |
| 80 | Dysphonia | Canada Vigilance: 6 | Canada Vigilance | |
| 81 | Emotional distress | OFFSIDES | ||
| 82 | Eosinophilic myocarditis | OFFSIDES | ||
| 83 | Epstein-Barr virus associated lymphoproliferative disorder | OFFSIDES | ||
| 84 | Erythema | Canada Vigilance: 5 | Canada Vigilance OFFSIDES | |
| 85 | Extremity contracture | OFFSIDES | ||
| 86 | Failure to Thrive | OFFSIDES | ||
| 87 | Feeling Cold | Canada Vigilance: 1 | Canada Vigilance | |
| 88 | Feeling abnormal | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 89 | Flank Pain | Canada Vigilance: 5 | Canada Vigilance | |
| 90 | Flatulence | OFFSIDES | ||
| 91 | Foaming at mouth | Canada Vigilance: 1 | Canada Vigilance | |
| 92 | Formication | OFFSIDES | ||
| 93 | Gastric ulcer | OFFSIDES | ||
| 94 | General physical health deterioration | OFFSIDES | ||
| 95 | Grip strength | OFFSIDES | ||
| 96 | Head discomfort | Canada Vigilance: 2 | Canada Vigilance | |
| 97 | Headache | Canada Vigilance: 10 | Canada Vigilance | |
| 98 | Hyperkeratosis | OFFSIDES | ||
| 99 | Hyperpigmentation | OFFSIDES | ||
| 100 | Hyperventilation | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 101 | Hypokinesia | OFFSIDES | ||
| 102 | Hypoxia | OFFSIDES | ||
| 103 | Implantable defibrillator insertion | OFFSIDES | ||
| 104 | Incontinence | OFFSIDES | ||
| 105 | Incorrect drug administration duration | OFFSIDES | ||
| 106 | Incorrect drug administration rate | Canada Vigilance: 1 | Canada Vigilance | |
| 107 | Infusion site burning | OFFSIDES | ||
| 108 | Infusion site mobility decreased | OFFSIDES | ||
| 109 | Infusion site rash | OFFSIDES | ||
| 110 | Infusion site urticaria | OFFSIDES | ||
| 111 | Injection site discomfort | OFFSIDES | ||
| 112 | Intentional misuse | OFFSIDES | ||
| 113 | Intentional product use issue | Canada Vigilance: 1 | Canada Vigilance | |
| 114 | Joint Instability | OFFSIDES | ||
| 115 | Joint Range of Motion Decreased | OFFSIDES | ||
| 116 | Joint stiffness | OFFSIDES | ||
| 117 | Lethargy | Canada Vigilance: 1 | Canada Vigilance | |
| 118 | Limb discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 119 | Lip swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 120 | Livedo Reticularis | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 121 | Loss of personal independence in daily activities | Canada Vigilance: 1 | Canada Vigilance | |
| 122 | Lung consolidation | OFFSIDES | ||
| 123 | Lymphedema | OFFSIDES | ||
| 124 | Lymphocyte percentage decreased | OFFSIDES | ||
| 125 | Lymphocytic infiltration | OFFSIDES | ||
| 126 | Malaise | Canada Vigilance: 2 | Canada Vigilance | |
| 127 | Metastatic bronchial carcinoma | OFFSIDES | ||
| 128 | Muscle Weakness | OFFSIDES | ||
| 129 | Muscle necrosis | OFFSIDES | ||
| 130 | Musculoskeletal Pain | Canada Vigilance: 3 | Canada Vigilance | |
| 131 | Musculoskeletal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 132 | Myalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 133 | Neck Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 134 | Nephrogenic Fibrosing Dermopathy | OFFSIDES | ||
| 135 | Neuralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 136 | Ocular discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 137 | Ocular icterus | OFFSIDES | ||
| 138 | Oropharyngeal swelling | OFFSIDES | ||
| 139 | Overdose | OFFSIDES | ||
| 140 | Pain | Canada Vigilance: 2 | Canada Vigilance OFFSIDES | |
| 141 | Pallor | Canada Vigilance: 8 | Canada Vigilance OFFSIDES | |
| 142 | Parakeratosis | OFFSIDES | ||
| 143 | Performance status decreased | OFFSIDES | ||
| 144 | Pericardial effusion | OFFSIDES | ||
| 145 | Peripheral arterial occlusive disease | OFFSIDES | ||
| 146 | Peripheral motor neuropathy | Canada Vigilance: 1 | Canada Vigilance | |
| 147 | Peripheral swelling | Canada Vigilance: 16 | Canada Vigilance | |
| 148 | Pityriasis | OFFSIDES | ||
| 149 | Pneumatic compression therapy | OFFSIDES | ||
| 150 | Pneumothorax | OFFSIDES | ||
| 151 | Portal Hypertension | OFFSIDES | ||
| 152 | Portal hypertensive gastropathy | OFFSIDES | ||
| 153 | Post inflammatory pigmentation change | OFFSIDES | ||
| 154 | Quality of life decreased | OFFSIDES | ||
| 155 | Renal pain | Canada Vigilance: 1 | Canada Vigilance | |
| 156 | Restless Legs Syndrome | Canada Vigilance: 1 | Canada Vigilance | |
| 157 | Scleroderma | OFFSIDES | ||
| 158 | Seroma | OFFSIDES | ||
| 159 | Shunt occlusion | OFFSIDES | ||
| 160 | Shunt stenosis | OFFSIDES | ||
| 161 | Shunt thrombosis | OFFSIDES | ||
| 162 | Skin Induration | OFFSIDES | ||
| 163 | Skin hypertrophy | OFFSIDES | ||
| 164 | Skin necrosis | OFFSIDES | ||
| 165 | Skin tightness | Canada Vigilance: 1 | Canada Vigilance OFFSIDES | |
| 166 | Steroid withdrawal syndrome | OFFSIDES | ||
| 167 | Subcutaneous nodule | OFFSIDES | ||
| 168 | Sudden death | OFFSIDES | ||
| 169 | Swelling of eyelid | Canada Vigilance: 2 | Canada Vigilance | |
| 170 | Swelling | Canada Vigilance: 2 | Canada Vigilance | |
| 171 | Syncope | Canada Vigilance: 2 | Canada Vigilance | |
| 172 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 173 | Throat irritation | Canada Vigilance: 2 | Canada Vigilance | |
| 174 | Tonic clonic movements | OFFSIDES | ||
| 175 | Urinary Incontinence | Canada Vigilance: 3 | Canada Vigilance | |
| 176 | Urinary tract infection | Canada Vigilance: 1 | Canada Vigilance | |
| 177 | Vertigo | Canada Vigilance: 1 | Canada Vigilance | |
| 178 | Wound dehiscence | OFFSIDES | ||
| 179 | bone marrow fibrosis | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.